Jacobs Levy Equity Management, Inc Vanda Pharmaceuticals Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q3 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 108,610 shares of VNDA stock, worth $472,453. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,610
Previous 165,993
34.57%
Holding current value
$472,453
Previous $783,000
30.91%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding VNDA
# of Institutions
162Shares Held
45.3MCall Options Held
159KPut Options Held
229K-
Black Rock Inc. New York, NY8.14MShares$35.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$15.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.48MShares$15.1 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.25MShares$14.1 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$11.2 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $246M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...